Delayed neuropsychiatric syndrome in a child following carbon monoxide poisoning

Akiko Kondo1, Yoshiaki Saito, Ayumi Seki

  • 1Divisions of Child Neurology, Institute of Neurological Sciences, Faculty of Medicine, Tottori University, Japan. holbergs@nifty.com

Brain & Development
|September 30, 2006
PubMed

Insights

Carbon monoxide (CO) poisoning can cause delayed neuropsychiatric syndrome in children, even after hyperbaric oxygen therapy. This case highlights atypical cortical laminar necrosis, suggesting complex CO poisoning pathomechanisms.

Area of Science:

  • Neurology
  • Toxicology
  • Pediatrics

Background:

  • Carbon monoxide (CO) poisoning is a significant public health concern, particularly in pediatric populations.
  • Hyperbaric oxygen (HBO) therapy is a standard treatment for CO poisoning, aiming to accelerate CO elimination and tissue oxygenation.
  • Delayed neuropsychiatric sequelae following CO poisoning, while known, are less commonly reported in children.

Observation:

  • A five-year-old boy presented with symptoms of CO poisoning and initially improved with HBO therapy.
  • He later developed delayed neurological deficits including lethargy, visual and gait disturbances, hemiparesis, and mood lability.
  • Electroencephalography showed slow frontal activity, and MRI revealed lesions in the hippocampus and cerebral cortex.

Findings:

  • The patient exhibited persistent neurological deficits despite a 10-day course of HBO therapy.
  • Follow-up MRI demonstrated lesions in the globus pallidum and characteristic cortical laminar necrosis.
  • These findings, particularly cortical laminar necrosis, are atypical for CO poisoning and suggest a broader pathomechanism.

Implications:

  • This case underscores the importance of vigilant, long-term neurological monitoring in children following CO exposure.
  • The atypical imaging findings challenge current understanding of CO poisoning's neuropathology.
  • Further research is warranted to elucidate the mechanisms underlying delayed neuropsychiatric syndrome and cortical lesions in pediatric CO poisoning.

Related Concept Videos

Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...